MediPal Holdings Corporation (TYO:7459)
2,566.50
-11.00 (-0.43%)
Aug 15, 2025, 3:30 PM JST
MediPal Holdings Market Cap
MediPal Holdings has a market cap or net worth of 529.37 billion as of August 15, 2025. Its market cap has decreased by -4.16% in one year.
Market Cap
529.37B
Enterprise Value
423.73B
Revenue
3.71T
Ranking
n/a
PE Ratio
13.06
Stock Price
2,566.50
Market Cap Chart
Since June 30, 1999, MediPal Holdings's market cap has increased from 47.56B to 529.37B, an increase of 1,013.06%. That is a compound annual growth rate of 9.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 529.37B | 6.94% |
Dec 30, 2024 | 495.03B | 2.54% |
Dec 29, 2023 | 482.78B | 32.07% |
Dec 30, 2022 | 365.54B | -19.21% |
Dec 30, 2021 | 452.47B | 11.20% |
Dec 30, 2020 | 406.91B | -19.69% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 10.29T |
Takeda Pharmaceutical Company | 6,805.61B |
HOYA Corporation | 6,796.90B |
Daiichi Sankyo Company | 6,635.63B |
Otsuka Holdings | 4,225.58B |
Terumo | 4,123.51B |
Astellas Pharma | 2,974.60B |
Shionogi & | 2,301.80B |